Flippin Bruce & Porter’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $11.2M | Sell |
310,306
-1,725
| -0.6% | -$61.2K | 2.03% | 16 |
|
|
2020
Q4 | $11.5M | Sell |
312,031
-26,075
| -8% | -$956K | 2.28% | 12 |
|
|
2020
Q3 | $11.8M | Sell |
338,106
-12,394
| -4% | -$435K | 2.64% | 9 |
|
|
2020
Q2 | $10.9M | Sell |
350,500
-19,909
| -5% | -$676K | 2.44% | 11 |
|
|
2020
Q1 | $11.5M | Buy |
370,409
+27,210
| +8% | +$927K | 2.81% | 9 |
|
|
2019
Q4 | $12.8M | Sell |
343,199
-10,280
| -3% | -$366K | 2.2% | 14 |
|
|
2019
Q3 | $12.1M | Sell |
353,479
-3,149
| -0.9% | -$115K | 2.14% | 13 |
|
|
2019
Q2 | $14.7M | Buy |
356,628
+4,834
| +1% | +$192K | 2.57% | 5 |
|
|
2019
Q1 | $14.2M | Buy |
351,794
+7,767
| +2% | +$311K | 2.54% | 7 |
|
|
2018
Q4 | $14.2M | Buy |
344,027
+13,587
| +4% | +$564K | 2.8% | 3 |
|
|
2018
Q3 | $13.8M | Buy |
330,440
+5,458
| +2% | +$210K | 2.57% | 4 |
|
|
2018
Q2 | $11.2M | Sell |
324,982
-2,440
| -0.7% | -$83.4K | 2.32% | 5 |
|
|
2018
Q1 | $11M | Buy |
327,422
+3,689
| +1% | +$127K | 2.38% | 7 |
|
|
2017
Q4 | $11.1M | Sell |
323,733
-5,806
| -2% | -$198K | 2.36% | 5 |
|
|
2017
Q3 | $11.2M | Sell |
329,539
-5,745
| -2% | -$185K | 2.46% | 5 |
|
|
2017
Q2 | $10.7M | Buy |
335,284
+4,969
| +2% | +$157K | 2.41% | 6 |
|
|
2017
Q1 | $10.7M | Buy |
330,315
+20,114
| +6% | +$634K | 2.48% | 6 |
|
|
2016
Q4 | $9.56M | Buy |
310,201
+11,696
| +4% | +$357K | 2.33% | 9 |
|
|
2016
Q3 | $9.59M | Buy |
298,505
+12,673
| +4% | +$424K | 2.66% | 6 |
|
|
2016
Q2 | $9.55M | Buy |
285,832
+9,543
| +3% | +$305K | 2.83% | 6 |
|
|
2016
Q1 | $7.77M | Buy |
276,289
+7,459
| +3% | +$213K | 2.46% | 9 |
|
|
2015
Q4 | $8.23M | Sell |
268,830
-3,910
| -1% | -$123K | 2.79% | 4 |
|
|
2015
Q3 | $8.13M | Buy |
272,740
+6,305
| +2% | +$202K | 2.88% | 5 |
|
|
2015
Q2 | $8.48M | Sell |
266,435
-1,355
| -0.5% | -$44.2K | 2.86% | 4 |
|
|
2015
Q1 | $8.84M | Sell |
267,790
-1,836
| -0.7% | -$58.4K | 3.05% | 4 |
|
|
2014
Q4 | $7.97M | Sell |
269,626
-1,254
| -0.5% | -$36K | 2.55% | 8 |
|
|
2014
Q3 | $7.6M | Buy |
270,880
+1,103
| +0.4% | +$31K | 2.52% | 8 |
|
|
2014
Q2 | $7.6M | Sell |
269,777
-17,159
| -6% | -$489K | 2.53% | 8 |
|
|
2014
Q1 | $8.74M | Sell |
286,936
-2,417
| -0.8% | -$72.1K | 2.79% | 7 |
|
|
2013
Q4 | $8.41M | Sell |
289,353
-1,311
| -0.5% | -$38.2K | 2.68% | 7 |
|
|
2013
Q3 | $7.92M | Sell |
290,664
-745
| -0.3% | -$20.3K | 2.73% | 6 |
|
|
2013
Q2 | $7.74M | Buy |
+291,409
| New | +$8.05M | 2.77% | 5 |
|
Other funds holding PFE
Flippin Bruce & Porter's PFE Position: Q1 2021 in Review
Flippin Bruce & Porter reduced its Pfizer (PFE) stake by 0.55% in Q1 2021, selling an estimated $61.2K and leaving 310,306 shares worth $11.2M. The position accounts for 2.03% of the portfolio, ranked #16.
Flippin Bruce & Porter first reported a position in PFE in Q2 2013 and has held it in 32 quarters since. The position peaked at $14.7M in Q2 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Flippin Bruce & Porter held 310,306 shares of Pfizer worth $11.2M as of Q1 2021.
- Flippin Bruce & Porter sold 1,725 Pfizer shares in Q1 2021, an estimated $61.2K.
- Pfizer made up 2.03% of Flippin Bruce & Porter's portfolio in Q1 2021, its #16 holding.
- Flippin Bruce & Porter first reported a position in Pfizer in Q2 2013 and has held it in 32 quarters since.
- Flippin Bruce & Porter's Pfizer position peaked at $14.7M in Q2 2019.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Flippin Bruce & Porter's 13F filing for Q1 2021, filed 4 May 2021.